Breakout session one: Methamphetamine treatments | 2025 NDARC Annual Research Symposium скачать в хорошем качестве

Breakout session one: Methamphetamine treatments | 2025 NDARC Annual Research Symposium

Session chair: Professor Steven Shoptaw (Professor Emeritus and Vice Chair for Research, Department of Family Medicine, UCLA) 00:00 - Start 01:12 - Lisdexamfetamine in the treatment of methamphetamine dependence | Professor Nadine Ezard 14:35 - PsiMA trial of Psilocybin assisted Psychotherapy for Methamphetamine use disorder | Professor Jonathan Brett 27:25 - Oral naltrexone bupropion combination pharmacotherapy for methamphetamine use disorder – a pilot trial in the Australian context | Dr Krista Siefried 40:27 - The Tina Trial: A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder | Professor Rebecca McKetin 54:25 - Semaglutide for methamphetamine use disorder: A pilot randomized trial | Dr David Goodman-Meza 1:00:30 - Ketamine assisted psychotherapy for methamphetamine use disorder: A pilot study | Dr Brendan Clifford 1:06:35 - Study protocol for a randomised controlled trial of lisdexamfetamine for the treatment of acute methamphetamine withdrawal | Dr Liam Acheson